Protein critical to gut lining repair

Scientists at Washington University School of Medicine in St. Louis have identified a protein essential to repairing the intestine’s inner lining.

That lining is among the body’s busiest highways, trod not only by the food we ingest but also by trillions of microorganisms that aid digestion. Because the intestine plays key roles in absorbing nutrients and containing the microbes, any damage must be fixed promptly.

The researchers report Sept. 6 in Science Express that a protein called Wnt5a is essential for reconstructing glands in the intestinal lining. The glands, called crypts of Lieberkühn, contain stem cells that continually pump out other cells that renew the gut lining, which is replaced every two to four weeks. The crypts look like dimples in the gut lining and are vulnerable to damage and loss from infection and inflammation.

“For example, inflammatory bowel disease can destroy huge stretches of the lining, including the crypts,” says senior author Thaddeus Stappenbeck, MD, PhD, associate professor of pathology and immunology. “If crypts can’t be repaired as the lining is rebuilt, their absence would place substantial stresses on crypts in healthy portions of the gut. So it’s important to better understand how the crypts are replaced.”

In the new study, Stappenbeck and his colleagues showed that when crypts are lost to injury in mice, the nearest surviving crypts expand into the damaged area and create an array of channels. These wound channels, which contain rapidly dividing stem cells, eventually subdivide into new crypts.

Stappenbeck found that cells that line the outer wall of the gut migrate to sites of damage within the inner lining to provide Wnt5a, a signaling molecule that stops stem cells from dividing. This shutdown triggers the formation of dimples in the wound channels that become new crypts.

Because mice that lack the Wnt5a gene aren’t viable, co-author Terry Yamaguchi, PhD, of the National Cancer Institute, bred mice in which scientists could selectively turn off the gene after the mice became adults. When the gut lining was injured and Wnt5a was disabled, the wound channels formed but failed to divide into crypts.

Washington University scientists showed that the Wnt5a protein stops intestinal stem cells from dividing, which triggers the formation of repair glands in the gut lining. Each green sphere above is composed of numerous intestinal stem cells, which are grown in culture in a laboratory. (Credit: Hiroyuki Miyoshi)

To further confirm the link between the gene and crypt repair, Hiroyuki Miyoshi, PhD, a postdoctoral fellow in Stappenbeck’s laboratory, devised a robust method for growing gut stem cells in test tubes. When he applied Wnt5a to the stem cells, they stopped dividing, proving that the protein was the critical ingredient for initiating crypt formation.

The scientists also showed that Wnt5a activated a signaling pathway in the stem cells that is known to stop cell proliferation. Stappenbeck, who also is an associate professor of developmental biology, is now planning additional studies of Wnt5a, including investigations of whether the protein plays similar roles elsewhere in the body.

“We’re also very curious about what causes the outer lining of the gut to send cells that make Wnt5a into the inner lining of the gut, because that’s not something we’ve seen previously,” he says. “Our best theory so far is that when this happens, the body may be reactivating a pathway it uses to construct the gut early in development.”

Other researchers have identified the Wnt5a protein in tumors, suggesting it may play a role in cancer. Scientists don’t know what that role is, but the new mouse model Yamaguchi developed may help solve the mystery.

Miyoshi H, Ajima R, Luo C T-Y, Yamaguchi TP, Stappenbeck TS. Wnt5a potentiates TGF-beta signaling to promote colonic crypt regeneration after tissue injury. Science Express, Sept. 6, 2012.

Funding from the National Institutes of Health (DK90251), the Pew Scholars Program for the Biomedical Sciences, the National Institute of Diabetes and Digestive and Kidney Diseases (5T35DK074375), the Washington University Digestive Disease Research Core (NIH P30-DK52574) and the National Cancer Institute supported this research.

Washington University School of Medicine’s 2,100
employed and volunteer faculty physicians also are the medical staff of
and St. Louis Children’s hospitals. The School of Medicine
is one of the leading medical research, teaching and patient care
institutions in the nation, currently ranked sixth in the nation by U.S.
News & World Repor
t. Through its affiliations with Barnes-Jewish
and St. Louis Children’s hospitals, the School of Medicine is linked to BJC HealthCare.